Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Novel therapies for glaucoma: a patent review 2007 – 2011 | Expert Opinion on Therapeutic Patents |
| 103 | 2012 |
Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon speciesAcipenser gueldenstaedti | Journal of Enzyme Inhibition and Medicinal Chemistry |
| 49 | 2011 |
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium | Bioorganic & Medicinal Chemistry Letters |
| 58 | 2011 |
Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives | Bioorganic & Medicinal Chemistry Letters |
| 23 | 2011 |
Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides | Bioorganic & Medicinal Chemistry Letters |
| 26 | 2011 |
Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Design, synthesis, and biological evaluation of 3‐benzenesulfonamide‐linked 3‐hydrazinoisatin derivatives as carbonic anhydrase inhibitors | Archiv der Pharmazie |
| 2024 | |
Sulfonamide‐incorporated bis(α‐aminophosphonates) as promising carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and X‐ray crystallographic studies | Archiv der Pharmazie |
| 2024 | |
Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors | ChemMedChem |
| 2024 | |
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets | Pharmacology & Therapeutics |
| 1 | 2024 |
Isosteviol – A new scaffold for the synthesis of carbonic anhydrase II inhibitors | Results in Chemistry |
| 2024 |